Erratum to: Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

Vol.23 No.2

Erratum

Erratum to: Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

Authors

Tsutomu Takeuchi¹ , Tsukasa Matsubara² , Taisuke Nitobe³ , Eiichi Suematsu⁴ , Syuji Ohta⁵ , Shigeru Honjo⁶ , Tohru Abe⁷ , Ami Yamamoto⁸ , Nobuyuki Miyasaka⁹ , The Japan Abatacept Study Group

Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
Department of Orthopedics, Matsubara Mayflower Hospital, 944-25 Fujita, Kato, Hyogo, 673-1462, Japan
Department of Orthopedics, Seihoku Chuoh Hospital, 41 Nunoyacho, Goshogawara, Aomori, 037-0053, Japan
Department of Internal Medicine and Rheumatology, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan
Department of Rheumatology, Taga General Hospital, 2-1-2 Kokubun-cho, Hitachi, Ibaraki, 316-0035, Japan
Honjo Rheumatism Clinic, 387-1 Futatsuka, Takaoka, Toyama, 933-8525, Japan
Division of Rheumatology, Clinical Immunology, Saitama Medical Center/School, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan
Bristol-Myers KK, 6-5-1, Nishi-shinjuku, Shinjuku-ku, Tokyo, 163-1328, Japan
Department of Medicine and Rheumatology and Global Center of Excellence, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yusima, Bunkyo-ku, Tokyo, 113-8519, Japan

Vol.23 No.2

Erratum

Authors

Received:

Accepted:

Published online:

Full Text

Abstract

Key words